Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
5 Leser
Artikel bewerten:
(0)

Live Cell Imaging Market 2015 by Product, Technology & by Application - Analysis & Global Forecast to 2019 for the $5.45 Billion Market

DUBLIN, May 19, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/pgdp27/live_cell_imaging) has announced the addition of the "Live Cell Imaging Market by Product, Technology & by Application - Analysis & Global Forecast to 2019" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The global live cell imaging market is expected to reach $5.45 Billion by 2019 from $3.57 Billion in 2014, growing at a CAGR of 8.8% from 2014 to 2019

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the fastest rate during the forecast period.

Over the years, the live cell imaging market has witnessed various technological advancements in order to study the functions of live cells that meet the needs of academic and government institutes, pharmaceutical and biotechnology industries, contract research organizations, and diagnostics laboratories. These advancements have led to the development of various technologies used for live cell imaging.

In 2014, the equipment segment accounted for the largest share of the live cell imaging market, by product; the microscopy segment accounted for the largest share of the live cell imaging market, by equipment; the assay kits segment accounted for the largest share of the live cell imaging market, by consumables; the fluorescence resonance energy transfer (FRET) segment accounted for the largest share of the live cell imaging market, by technology; and the cell biology segment accounted for the largest share of live cell imaging market, by application.

In 2014, North America accounted for the largest share of the live cell imaging market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the live cell imaging market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of equipment, consumables, and software involved in live cell imaging.

The global live cell imaging market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Some of the major players in the global market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

For more information visit http://www.researchandmarkets.com/research/pgdp27/live_cell_imaging


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.